- Home
- EDAP vs ADAG Comparison
EDAP vs ADAG Comparison
Compare EDAP & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDAP
- ADAG
- Stock Information
- Founded
- EDAP 1979
- ADAG 2011
- Country
- EDAP France
- ADAG China
- Employees
- EDAP N/A
- ADAG N/A
- Industry
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- EDAP Health Care
- ADAG Health Care
- Exchange
- EDAP Nasdaq
- ADAG Nasdaq
- Market Cap
- EDAP 94.2M
- ADAG 95.6M
- IPO Year
- EDAP 1997
- ADAG 2021
- Fundamental
- Price
- EDAP $2.45
- ADAG $2.14
- Analyst Decision
- EDAP Strong Buy
- ADAG Strong Buy
- Analyst Count
- EDAP 2
- ADAG 1
- Target Price
- EDAP $14.00
- ADAG $5.00
- AVG Volume (30 Days)
- EDAP 207.4K
- ADAG 73.9K
- Earning Date
- EDAP 11-07-2024
- ADAG 07-25-2024
- Dividend Yield
- EDAP N/A
- ADAG N/A
- EPS Growth
- EDAP N/A
- ADAG N/A
- EPS
- EDAP N/A
- ADAG N/A
- Revenue
- EDAP $70,722,730.00
- ADAG $815,746.00
- Revenue This Year
- EDAP $8.00
- ADAG N/A
- Revenue Next Year
- EDAP $14.58
- ADAG $2.70
- P/E Ratio
- EDAP N/A
- ADAG N/A
- Revenue Growth
- EDAP 12.17
- ADAG N/A
- 52 Week Low
- EDAP $2.27
- ADAG $1.34
- 52 Week High
- EDAP $8.50
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- EDAP 38.04
- ADAG 37.47
- Support Level
- EDAP $2.42
- ADAG $2.20
- Resistance Level
- EDAP $2.72
- ADAG $3.14
- Average True Range (ATR)
- EDAP 0.17
- ADAG 0.30
- MACD
- EDAP -0.02
- ADAG -0.09
- Stochastic Oscillator
- EDAP 6.23
- ADAG 18.63
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.